Tatjana Belovari

Tatjana Belovari

Auto-generated profile, based on publicly available information

Tatjana Belovari

Department of Histology and Embryology, Faculty of Medicine, Josip Juraj Strossmayer University, Osijek, Croatia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 November 2020 in Southeastern European medical journal
Verified
Journal Article
Open access
PDF file
NBNikola Bijelić
Nikola Bijelić
MAMartina Abramović
Martina Abramović
JRJasmina Rajc
Jasmina Rajc
EREdi Rođak
Edi Rođak
ZMZlatko Marušić
Zlatko Marušić
TBTatjana Belovari
Tatjana Belovari
Aim: Trefoil factor family 3 (TFF3) peptide is normally expressed by epithelial cells in breast ducts, but it is also associated with different pathological conditions, including breast cancer. It is considered a marker of poor prognosis and associated with increased resistance to chemotherapy. Data on the effect of chemotherapy on TFF3 peptide expression are scarce. The aim of this pilot study was to assess suitability of research on this topic for large-scale studies. Methods: Formalin-fixed, paraffin-embedded samples of core biopsies and of surgically removed tumors from patients with luminal B subtype of breast cancer were used for immunohistochemical analysis. Changes in TFF3 peptide and Ki-67 expression and microvessel density (MVD) values before and after chemotherapy were analyzed, as well as the association between TFF3 peptide expression and Ki-67 expression and MVD values. Results: Significant reduction in TFF3 and Ki 67 expression was observed after chemotherapy, while MVD values did not differ significantly before and after chemotherapy. The association of TFF3 peptide expression and Ki-67 expression and TFF3 peptide expression and MVD values was not significant before or after chemotherapy. Conclusion: The data obtained in this pilot study suggest that a large-scale study is justified, and it other breast cancer subtypes should be included.

1 November 2022 in Cardiologia Croatica
Verified
Journal Article
Closed access
DVDomagoj Vučić
Domagoj Vučić
NBNikola Bijelić
Nikola Bijelić
EREdi Rođak
Edi Rođak
JRJasmina Rajc
Jasmina Rajc
BDBoris Dumenčić
Boris Dumenčić
KSKristina Selthofer-Relatić
Kristina Selthofer-Relatić